Valbiotis
ALVAL | PA
Overview
Corporate Details
- ISIN(s):
- FR0013254851
- LEI:
- 969500VP4JBJCF0MOP60
- Country:
- France
- Address:
- RUE PAUL VATINE, 17180 PERIGNY
- Website:
- https://www.valbiotis.com/en/
- Sector:
- Professional, scientific and technical activities
- Industry:
- Research and experimental development on natural sciences and engineering
Description
Valbiotis is a Research & Development company dedicated to scientific innovation for preventing and combating metabolic and cardiovascular diseases. To achieve this goal, Valbiotis has developed an exclusive and unique scientific approach founded on specific combinations of plant-based molecules. The active substances, which are called “Totum”, act directly on the key metabolic parameters of the body. Our unique approach focuses on prevention by providing health nutrition solutions.
Stop Scraping. Start Analyzing.
You're viewing a fraction of the data available for Valbiotis.
Get complete, real-time, and AI-ready data via the API the pros use.
Filings
| Date | Filing | Language | Size | Actions |
|---|---|---|---|---|
| 2025-08-11 17:30 |
Declaration of Voting Results & Voting Rights Announcements
VALBIOTIS SA: Information mensuelle relative au nombre total de droits de vote …
|
French | 18.2 KB | |
| 2025-07-03 17:45 |
Declaration of Voting Results & Voting Rights Announcements
VALBIOTIS SA: Information mensuelle relative au nombre total de droits de vote …
|
French | 165.4 KB | |
| 2025-07-03 17:45 |
Regulatory News Service
VALBIOTIS SA: Bilan semestriel du contrat de liquidité
|
French | 359.3 KB | |
| 2025-07-03 17:45 |
Declaration of Voting Results & Voting Rights Announcements
VALBIOTIS SA: Information mensuelle relative au nombre total de droits de vote …
|
French | 19.3 KB | |
| 2025-06-26 17:40 |
Share Issue/Capital Change
VALBIOTIS SA: Valbiotis announces the success of its €6.9 million rights issue …
|
English | 470.3 KB | |
| 2025-06-26 17:40 |
Share Issue/Capital Change
VALBIOTIS SA: Valbiotis annonce le succès de son augmentation de capital de 6,9…
|
French | 419.2 KB | |
| 2025-06-26 17:40 |
Share Issue/Capital Change
VALBIOTIS SA: Valbiotis announces the success of its 6.9 million rights issue e…
|
English | 142.5 KB | |
| 2025-06-06 08:00 |
Share Issue/Capital Change
VALBIOTIS SA: Valbiotis announces the launch of a capital increase with maintai…
|
English | 579.9 KB | |
| 2025-06-06 08:00 |
Share Issue/Capital Change
VALBIOTIS SA: Valbiotis annonce le lancement d’une augmentation de capital avec…
|
French | 511.1 KB | |
| 2025-06-06 08:00 |
Share Issue/Capital Change
VALBIOTIS SA: Valbiotis announces the launch of a capital increase with maintai…
|
English | 305.6 KB | |
| 2025-06-02 22:48 |
Declaration of Voting Results & Voting Rights Announcements
VALBIOTIS SA: Information mensuelle relative au nombre total de droits de vote …
|
French | 131.2 KB | |
| 2025-06-02 22:48 |
Declaration of Voting Results & Voting Rights Announcements
VALBIOTIS SA: Information mensuelle relative au nombre total de droits de vote …
|
French | 18.1 KB | |
| 2025-05-22 17:40 |
Earnings Release
VALBIOTIS SA: Valbiotis to launch ValbiotisPRO® Cardio-circulation on 2 June
|
English | 235.0 KB | |
| 2025-05-22 17:40 |
Regulatory News Service
VALBIOTIS SA: Valbiotis commercialisera le 2 juin prochain sa solution Valbio…
|
French | 201.0 KB | |
| 2025-05-22 17:40 |
Regulatory News Service
VALBIOTIS SA: Valbiotis to launch ValbiotisPRO Cardio-circulation on 2 June
|
English | 27.2 KB |
Automate Your Workflow. Get a real-time feed of all Valbiotis filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Need More History? Access decades of standardized financials for Valbiotis via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| 2023-01-17 | N/A | Other | Other | 10,400 | 46,072.00 EUR |
Peer Companies
| Company | Country | Ticker | View | |
|---|---|---|---|---|
|
HEMOGENYX PHARMACEUTICALS PLC | United Kingdom | HEMO | |
|
Herantis Pharma Oyj | Finland | HRTIS | |
| Hiron-Trade Investments & Industrial Buildings Ltd. | Israel | HRON | ||
|
Human Stem Cells Institute PJSC | Russian Federation | ISKJ | |
|
Human Xtensions Ltd. | Israel | HUMX | |
|
Hybrigenics SA | France | ALHYG | |
|
Hyloris Pharmaceuticals SA | Belgium | HYL | |
|
Ikonisys S.A. | France | ALIKO | |
|
IMCB PJSC | Russian Federation | GEMA | |
|
Immunic AG | United States of America | IMUX |